Stifel analyst Stephen Gengaro lowered the firm’s price target on Core Laboratories (CLB) to $13 from $15 and keeps a Hold rating on the shares after the company delivered “mixed” Q1 results.

Good day, and welcome to the Core Laboratories First Quarter 2025 Earnings Conference Call. (Operator Instructions) Please note, this event is being recorded. I'd now like to hand the call to ...

Good day, and welcome to the Core Laboratories First Quarter 2025 Earnings Conference Call. (Operator Instructions) Please note, this event is being recorded. I'd now like to hand the call to Larry ...

Core Laboratories (CLB), a $611.8 million market cap energy services company, reported its Q1 2025 earnings, revealing a significant miss on both earnings per share (EPS) and revenue forecasts. The ...

EXCLUSIVE: Oscillosope Laboratories has settled on its U.S. release plan for Mistress Dispeller, the acclaimed documentary from filmmaker Elizabeth Lo (Stray), Anonymous Content and Impact Partners.

Core Laboratories (CLB), a $611.8 million market cap energy services company, reported its Q1 2025 earnings, revealing a significant miss on both earnings per share (EPS) and revenue forecasts.

With a substantially reduced cost of ownership and lower running costs, Beacon Discovery lowers the barrier to entry for researchers and core labs exploring immuno-oncology, infectious diseases ...

HOUSTON - Core Laboratories N.V. (NYSE:CLB) reported first quarter earnings that fell short of analyst expectations, sending shares down 3.1% in after-hours trading. The oil services company posted ...

The shift towards home-based working following the Covid-19 pandemic, and the simultaneous decline of high street shopping presents a unique opportunity to develop more urban labs, located in the very ...

Core Laboratories Inc. has a twelve month low of $10.14 and a twelve month high of $25.13. The stock’s 50 day moving average is $14.23 and its 200-day moving average is $17.30.